- News & Analysis
Page 111
SAP Ventures makes good call on JustDial
SAP Ventures' recently listed investee company JustDial closes 22% above issue price.
Jun 13, 2013Tecogen powers to IPO
SoCal Gas-backed Tecogen files for Nasdaq IPO to raise $25 million.
Jun 11, 2013Epizyme raises $77m in flotation
Epizyme sold 5.1 million shares at $15 each compared to plans to offer 4.285 million shares at between $13 and $15 each.
Jun 1, 2013Regado looks for $70m from Nasdaq
It will list 5 million shares at between $14 and $16 each to give an initial market capitalisation of about $215m, were it to price in the middle of its range.
May 28, 2013Nanostring pulls on flotation
In December, Morgan Stanley co-led a $15.3m series E preferred stock round of financing into NanoString Technologies.
May 28, 2013Epizyme to offer 4.285 million shares
Celgene owns 14.5% of Epizyme ahead of the initial public offering (IPO), after investing the portfolio company's series C round.
May 28, 2013Portola sets IPO price range
Biogen Idec-backed Portola Pharmaceuticals set to raise around $103.2m on Nasdaq with $469m market cap
May 14, 2013About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2025 Mawsonia Ltd. All rights reserved.test regLogin